Luke Dow, PhD, discusses the next steps for researching the Wnt pathway in colorectal cancer.
Luke Dow, PhD
Advertisement
Articles by Luke Dow, PhD
Luke Dow, PhD, discusses phase I trials targeting the Wnt signaling pathway in colorectal cancer.
Advertisement
Latest Updated Articles
Targeting Wnt in BRAF-Mutant Colorectal CancerOctober 28th 2019
Next Steps for Wnt Research in Colorectal CancerDecember 5th 2019
Advertisement
Advertisement
Trending on OncLive
1
FDA CTGTAC Votes in Favor of RP1/Nivolumab Data in Advanced Melanoma
2
FDA Grants Priority Review to Subcutaneous Amivantamab in Head and Neck Cancer
3
FDA Awards Orphan Drug Designation to Enzomenib for ALL
4
Dana-Farber Researchers Identify CDK8 as a Potential Therapeutic Target for Alveolar Rhabdomyosarcoma
5